FDA submission for early feasibility study, page-38

There was a lot of 'excitement' as the two phases of the clinical trial took place. the one month results were very good news. I believe people reacted hence the price rise (amongst other reasons I am sure). Now, as we wait for the next 'official' trial results, people get itchy fingers and get sick of waiting, lose interest and relieve them selves of shares. The first wave of trial results are due before the end of the year, and the next phase results 6 months after that. And those results alone may not see a change in buyer sentiment, however, they are all steps towards product approval and commercialisation - and that should hopefully support a share price rise.